EBO Stock Overview Engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
EBOS Group Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for EBOS Group Historical stock prices Current Share Price NZ$36.18 52 Week High NZ$35.79 52 Week Low NZ$28.75 Beta 0.25 1 Month Change 6.44% 3 Month Change 10.47% 1 Year Change 5.30% 3 Year Change -3.42% 5 Year Change 61.66% Change since IPO 335.90%
Recent News & Updates
EBOS Group Limited Appoints Grant Viney as Chief Executive Officer of EBOS Animal Care , Effective 1 February 2025 Jan 22
EBOS Group Limited to Report First Half, 2025 Results on Jan 19, 2025 Jan 14
EBOS Group Limited Appoints Matthew Muscio as Director Jan 03
Now 21% undervalued Dec 27
Now 21% undervalued Dec 04 EBOS Group Limited Announces the Retirement of Peter Williams as Director See more updates
EBOS Group Limited Appoints Grant Viney as Chief Executive Officer of EBOS Animal Care , Effective 1 February 2025 Jan 22
EBOS Group Limited to Report First Half, 2025 Results on Jan 19, 2025 Jan 14
EBOS Group Limited Appoints Matthew Muscio as Director Jan 03
Now 21% undervalued Dec 27
Now 21% undervalued Dec 04 EBOS Group Limited Announces the Retirement of Peter Williams as Director
Final dividend of NZ$0.64 announced Aug 23
EBOS Group Limited Announces Final Dividend, Payable on 18 September 2024 Aug 23
Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Aug 21
EBOS Group Limited Announces Chief Financial Officer Changes Apr 27
Insider recently sold AU$4.9m worth of stock Mar 08
First half dividend of NZ$0.60 announced Feb 25
First half 2024 earnings released: EPS: AU$0.71 (vs AU$0.70 in 1H 2023) Feb 22 EBOS Group Limited to Report Fiscal Year 2024 Results on Aug 21, 2024
Now 20% undervalued Feb 02
EBOS Group Limited to Report First Half, 2024 Results on Feb 21, 2024 Jan 10
EBOS Group Limited (NZSE:EBO) acquired additional 39% stake in Transmedic Pte Ltd. from TS Lee for approximately SGD 120 million. Dec 20
Paragon Care Reportedly Taps Rothschild for Defence Amid Buyout Talk Dec 15
EBOS Reportedly Runs Eye over Paragon Care after Abandoning Greencross Pursuit Dec 07
EBOS Not to Proceed with Acquisition in Animal Care Segment Nov 24
EBOS Not to Proceed with Acquisition in Animal Care Segment Nov 23
Now 21% undervalued Nov 13
EBOS Group Limited Announces Fully Franked Ordinary Dividend for the Six Months Ended June 30, 2023, Payable on 29 September, 2023 Sep 27
Now 21% undervalued Sep 05
Upcoming dividend of NZ$0.60 per share at 3.0% yield Aug 31 Ebos Group Limited Announces Dividend, Payable on 29 September 2023
Full year 2023 earnings: Revenues and EPS in line with analyst expectations Aug 23
Investor sentiment deteriorates as stock falls 17% Jun 07
Now 26% undervalued after recent price drop Jun 06
First half 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Feb 22 EBOS Group Limited to Report Q2, 2023 Results on Feb 22, 2023
EBOS Group Limited Announces the Appointment of Mark Bloom as an Independent Director, Effective 16 September 2022 Sep 15
Upcoming dividend of NZ$0.51 per share Sep 01
Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Aug 24
EBOS Group Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 30 September, 2022 Aug 24
Upcoming dividend of NZ$0.49 per share Feb 24
First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Feb 18 EBOS Group Limited Announces Fully Franked Ordinary Dividend for the Six Months Ended December 31, 2021, Payable on March 18, 2022
Ebos Group Limited Announces Resignation of Nick Dowling as Director Feb 08
Independent Director recently bought AU$55k worth of stock Dec 19
Price target increased to AU$31.66 Nov 03
EBOS Group Limited Announces Supplementary Dividend for the Six Months Ended June 30, 2021, Payable on Sept. 24, 2021 Sep 24
Upcoming dividend of NZ$0.48 per share Sep 02
EBOS Group Limited (EBOS) acquired Sentry Medical. Sep 01
Full year 2021 earnings released: EPS AU$1.13 (vs AU$1.01 in FY 2020) Aug 23
EBOS Group Limited (NZSE:EBO) acquired Pioneer Medical Limited for AUD 40 million. Aug 18
Price target raised to AU$25.70 Feb 20
First half 2021 earnings released: EPS AU$0.57 (vs AU$0.51 in 1H 2020) Feb 19
Revenue beats expectations Feb 19
EBOS Group Limited (NZSE:EBO) acquired Vet Distribution Business of Clifford Hallam Healthcare Pty Ltd for AUD 9.2 million. Feb 18 EBOS Group Limited (NZSE:EBO) acquired CH2 Vet for AUD 9.2 million.
EBOS Group Limited, Annual General Meeting, Oct 19, 2021 Feb 01
New 90-day high: AU$27.92 Jan 04
New 90-day high: AU$25.25 Dec 15
EBOS Group Limited (NZSE:EBO) entered into an agreement to acquire Cryomed Aesthetics Pty Limited for AUD 14.1 million. Oct 13
New 90-day high: AU$23.26 Oct 13
New 90-day high - AU$21.38 Sep 01
Full year earnings released - EPS AU$1.01 Aug 21
New 90-day low - AU$20.00 Aug 13 Shareholder Returns EBO AU Healthcare AU Market 7D 7.6% 3.4% 1.3% 1Y 5.3% -2.4% 10.3%
See full shareholder returns
Return vs Market: EBO underperformed the Australian Market which returned 10.3% over the past year.
Price Volatility Is EBO's price volatile compared to industry and market? EBO volatility EBO Average Weekly Movement 2.6% Healthcare Industry Average Movement 5.4% Market Average Movement 7.9% 10% most volatile stocks in AU Market 16.4% 10% least volatile stocks in AU Market 2.9%
Stable Share Price: EBO has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: EBO's weekly volatility (3%) has been stable over the past year.
About the Company EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services.
Show more EBOS Group Limited Fundamentals Summary How do EBOS Group's earnings and revenue compare to its market cap? EBO fundamental statistics Market cap AU$6.92b Earnings (TTM ) AU$271.55m Revenue (TTM ) AU$13.19b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) EBO income statement (TTM ) Revenue AU$13.19b Cost of Revenue AU$11.56b Gross Profit AU$1.63b Other Expenses AU$1.36b Earnings AU$271.55m
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 18, 2025
Earnings per share (EPS) 1.39 Gross Margin 12.38% Net Profit Margin 2.06% Debt/Equity Ratio 51.1%
How did EBO perform over the long term?
See historical performance and comparison Dividends
3.1% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/31 10:51 End of Day Share Price 2025/01/31 00:00 Earnings 2024/06/30 Annual Earnings 2024/06/30
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources EBOS Group Limited is covered by 16 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Saul Hadassin Barrenjoey Markets Pty Limited Benjamin Brayshaw Barrenjoey Markets Pty Limited Lyanne Harrison BofA Global Research
Show 13 more analysts 
